Order:
Disambiguations
Danielle M. Wenner [18]Danielle Wenner [2]D. Wenner [1]D. M. Wenner [1]
See also
Danielle M. Wenner
Carnegie Mellon University
Danielle Wenner
Rice University
  1.  16
    Nondomination and the Limits of Relational Autonomy.Danielle M. Wenner - 2020 - International Journal of Feminist Approaches to Bioethics 13 (2):28-48.
    Relational autonomy theorists attempt to accommodate social embeddedness within a conception of autonomy. These attempts are conceptually messy, at best, and category errors, at worst. Rejecting the liberal conception of autonomy due to feminist concerns is more helpfully answered by the neorepublican notion of freedom as nondomination. The conception of freedom as nondomination captures the values that motivate the relational turn in moral and political theory and does so in a conceptually neater way than attempting to accommodate those concerns in (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   7 citations  
  2.  40
    The Social Value Requirement in Research: From the Transactional to the Basic Structure Model of Stakeholder Obligations.Danielle M. Wenner - 2018 - Hastings Center Report 48 (6):25-32.
    It has long been taken for granted that clinical research involving human subjects is ethical only if it holds out the prospect of producing socially valuable knowledge. Recently, this social value requirement has come under scrutiny, with prominent ethicists arguing that the social value requirement cannot be substantiated as an ethical limit on clinical research, and others attempting to offer new support. In this paper, I argue that both criticisms and existing defenses of the social value requirement are predicated on (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   10 citations  
  3.  24
    The Social Value of Knowledge and the Responsiveness Requirement for International Research.Danielle M. Wenner - 2017 - Bioethics 31 (2):97-104.
    Ethicists have long recognized that two necessary features of ethical research are scientific validity and social value. Yet despite a significant literature surrounding the validity component of this dictate, until recently there has been little attention paid to unpacking what the social value component might require. This article introduces a framework for assessing the social value of research, and in particular, for determining whether a given research program is likely to have significant social value of the kind necessary to fulfill (...)
    Direct download  
     
    Export citation  
     
    Bookmark   8 citations  
  4. Against Permitted Exploitation in Developing World Research Agreements.Danielle M. Wenner - 2016 - Developing World Bioethics 16 (1):36-44.
    This paper examines the moral force of exploitation in developing world research agreements. Taking for granted that some clinical research which is conducted in the developing world but funded by developed world sponsors is exploitative, it asks whether a third party would be morally justified in enforcing limits on research agreements in order to ensure more fair and less exploitative outcomes. This question is particularly relevant when such exploitative transactions are entered into voluntarily by all relevant parties, and both research (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark   4 citations  
  5.  22
    The Social Value of Knowledge and International Clinical Research.Danielle M. Wenner - 2015 - Developing World Bioethics 15 (2):76-84.
    In light of the growth in the conduct of international clinical research in developing populations, this paper seeks to explore what is owed to developing world communities who host international clinical research. Although existing paradigms for assigning and assessing benefits to host communities offer valuable insight, I criticize their failure to distinguish between those benefits which can justify the conduct of research in a developing world setting and those which cannot. I argue that the justification for human subjects research is (...)
    Direct download  
     
    Export citation  
     
    Bookmark   7 citations  
  6. Patient-Funded Trials: Opportunity or Liability?Danielle M. Wenner, Alex John London & Jonathan Kimmelman - 2015 - Cell Stem Cell 17 (2):135-137.
    Patient-funded trials are gaining traction as a means of accelerating clinical translation. However, such trials sidestep mechanisms that promote rigor, relevance, efficiency, and fairness. We recommend that funding bodies or research institutions establish mechanisms for merit review of patient-funded trials, and we offer some basic criteria for evaluating PFT protocols.
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   3 citations  
  7.  21
    Barriers to Effective Deliberation in Clinical Research Oversight.Danielle Wenner - 2016 - HEC Forum 28 (3):245-259.
    Ethical oversight of clinical research is one of the primary means of ensuring that human subjects are protected from the natural bias of researchers and research institutions in favor of experimentation. At a minimum, effective oversight should ensure that risks are minimized and reasonable in relation to anticipated benefits, protect vulnerable subjects from potential coercion or undue influence, ensure full and informed consent, and promote the equitable distribution of the risks and benefits of research. Because these assessments often involve value (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark   5 citations  
  8. A taxonomy of multinational ethical and methodological standards for clinical trials of therapeutic interventions.C. M. Ashton, N. P. Wray, A. F. Jarman, J. M. Kolman, D. M. Wenner & B. A. Brody - 2011 - Journal of Medical Ethics 37 (6):368-373.
    Background If trials of therapeutic interventions are to serve society's interests, they must be of high methodological quality and must satisfy moral commitments to human subjects. The authors set out to develop a clinical - trials compendium in which standards for the ethical treatment of human subjects are integrated with standards for research methods. Methods The authors rank-ordered the world's nations and chose the 31 with >700 active trials as of 24 July 2008. Governmental and other authoritative entities of the (...)
    Direct download (14 more)  
     
    Export citation  
     
    Bookmark   4 citations  
  9. Conflicts among Multinational Ethical and Scientific Standards for Clinical Trials of Therapeutic Interventions.Jacob M. Kolman, Nelda P. Wray, Carol M. Ashton, Danielle M. Wenner, Anna F. Jarman & Baruch A. Brody - 2012 - Journal of Law, Medicine and Ethics 40 (1):99-121.
    There has been a growing concern over establishing norms that ensure the ethically acceptable and scientifically sound conduct of clinical trials. Among the leading norms internationally are the World Medical Association's Declaration of Helsinki, guidelines by the Council for International Organizations of Medical Sciences, the International Conference on Harmonization's standards for industry, and the CONSORT group's reporting norms, in addition to the influential U.S. Federal Common Rule, Food and Drug Administration's body of regulations, and information sheets by the Department of (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  10. Research ethics: Ethics and methods in surgical trials.C. Ashton, N. Wray, A. Jarman, J. Kolman & D. Wenner - 2009 - Journal of Medical Ethics 35 (9):579-583.
    This paper focuses on invasive therapeutic procedures, defined as procedures requiring the introduction of hands, instruments, or devices into the body via incisions or punctures of the skin or mucous membranes performed with the intent of changing the natural history of a human disease or condition for the better. Ethical and methodological concerns have been expressed about studies designed to evaluate the effects of invasive therapeutic procedures. Can such studies meet the same standards demanded of those, for example, evaluating pharmaceutical (...)
    Direct download (10 more)  
     
    Export citation  
     
    Bookmark   3 citations  
  11.  55
    Puberty-Blocking Treatment and the Rights of Bad Candidates.B. R. George & Danielle M. Wenner - 2019 - American Journal of Bioethics 19 (2):80-82.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  12.  14
    Exploitation and International Clinical Research: The Disconnect Between Goals and Policy.Danielle M. Wenner - 2018 - In David Boonin (ed.), The Palgrave Handbook of Philosophy and Public Policy. Cham, Switzerland: Springer Verlag. pp. 563-574.
    A growing proportion of clinical research funded by pharmaceutical companies, high-income country research agencies, and not-for-profit funders is conducted in low- and middle-income settings. Disparities in wealth and access to healthcare between the populations where new interventions are often tested and those where many of them are ultimately marketed raise concerns about exploitation. This chapter examines several ethical requirements frequently advanced as mechanisms for protecting research subjects in underserved communities from exploitation and evaluates the effectiveness of those mechanisms as responses (...)
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  13.  25
    The Need for Non-Ideal Theory: A Case Study in Deliberative Democracy.Danielle M. Wenner - 2017 - In M. Weber & Kevin Vallier (eds.), Political Utopias: Contemporary Debates. Oxford, UK: pp. 203-231.
    Direct download  
     
    Export citation  
     
    Bookmark   1 citation  
  14.  4
    Licensing Domination: Foreign Will and Social Benefit.Danielle M. Wenner - 2019 - American Journal of Bioethics 19 (9):60-62.
    Volume 19, Issue 9, September 2019, Page 60-62.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  15.  25
    Discharging the Duty to Conduct International Clinical Research.Danielle M. Wenner - 2012 - American Journal of Bioethics 12 (11):44-46.
  16.  10
    Do Surgical Trials Meet the Scientific Standards for Clinical Trials.Danielle M. Wenner, Baruch A. Brody, Anna Jarman, Jacob M. Kolman, Nelda Wray & Carol Ashton - 2012 - Journal of the American College of Surgeons 215 (5):722-730.
    No categories
    Direct download  
     
    Export citation  
     
    Bookmark   2 citations  
  17. Diversion Effects, Incentive Effects, and the Goals of Research Ethics Promulgations.Danielle M. Wenner - 2015 - Journal of Law and the Biosciences.
  18.  3
    Trials and Tribulations: The Professional Development of Surgical Trialists.Danielle M. Wenner, Anna Jarman, Nelda Wray & Carol Ashton - 2012 - American Journal of Surgery 204 (3):339-346.
    No categories
    Direct download  
     
    Export citation  
     
    Bookmark   2 citations  
  19.  26
    Not just a tragic compromise: The positive case for adolescent access to puberty-blocking treatment.Danielle M. Wenner & B. R. George - 2021 - Bioethics 35 (9):925-931.
  20.  12
    Incorporating Health Equity Into COVID-19 Reopening Plans: Policy Experimentation in California.Emily A. Largent, Govind Persad, Michelle M. Mello, Danielle M. Wenner, Daniel B. Kramer, Brownsyne Tucker Edmonds & Monica Peek - 2021 - American Journal of Public Health 1 (1):e1-e8.
    California has focused on health equity in the state’s COVID-19 reopening plan. The Blueprint for a Safer Economy assigns each of California’s 58 counties into 1 of 4 tiers based on 2 metrics: test positivity rate and adjusted case rate. To advance to the next less-restrictive tier, counties must meet that tier’s test positivity and adjusted case rate thresholds. In addition, counties must have a plan for targeted investments within disadvantaged communities, and counties with more than 106 000 residents must (...)
    Direct download  
     
    Export citation  
     
    Bookmark  
  21.  17
    Danielle M. Wenner Replies.Danielle M. Wenner - 2019 - Hastings Center Report 49 (2):47-47.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  22.  12
    Henk ten Have: Global bioethics: An introduction: New York, Routledge, 2016, 312 pp, $53.95. [REVIEW]Danielle M. Wenner - 2016 - Monash Bioethics Review 34 (2):152-155.
    Direct download  
     
    Export citation  
     
    Bookmark